Table 1.

Characteristics of participants in 3 populations according to CC and TT genotypes of APOA2 –265T >C¹

	TT		CC
	Low-SFA intake	High-SFA intake	Low-SFA intake	High-SFA intake
BPRHS
n = 80	20	20	20	20
Women, %	50	50	50	50
Age, y	59.5 ± 6.8	59.6 ± 6.8	59.5 ± 6.7	58.6 ± 7.6
Drinker, %	30	60	35	60
Smoker, %	10	25	35	30
BMI, kg/m2	31.6 ± 5.8	31.2 ± 5.6	29.4 ± 6.0	34.0 ± 5.72
SFA, g/d	14.0 ± 4.2	33.7 ± 8.62	14.6 ± 5.0	35.1 ± 12.62
Total energy, kcal	1699 ± 561	3000 ± 6302	1522 ± 416	2932 ± 6912
GOLDN
n = 379	107	165	39	68
Women, %	77	42	85	40
Age, y	46.3 ± 16.8	41.5 ± 14.0	43.8 ± 15.8	43.4 ± 12.7
Drinker, %	47	45	64	54
Smoker, %	26	26	31	29
BMI, kg/m2	27.9 ± 5.5	26.8 ± 5.0	27.1 ± 5.4	29.1 ± 5.9
SFA, g/d	15.3 ± 4.5	38.0 ± 20.82	15.9 ± 4.0	41.1 ± 19.52
Total energy, kcal	1351 ± 383	2599 ± 14072	1367 ± 402	2884 ± 12082
FHS
n = 243	74	96	34	39
Women, %	73	56	71	62
Age, y	65.1 ± 9.3	62.1 ± 8.2	65.4 ± 9.4	64.4 ± 7.7
Drinker, %	76	72	91	82
Smoker, %	12	4	6	10
BMI, kg/m2	25.3 ± 4.2	27.5 ± 5.42	25.4 ± 3.7	26.7 ± 4.5
SFA, g/d	16.1 ± 4.2	31.6 ± 9.22	15.9 ± 4.3	30.6 ± 7.62
Total energy, kcal	1532 ± 349	2284 ± 5122	1528 ± 337	2336 ± 5372

¹Age, BMI, SFA, total energy are expressed as means ± SDs. APOA2, apolipoprotein A-II; BPRHS, Boston Puerto Rican Health Study; FHS, Framingham Heart Study; GOLDN, Genetics of Lipid Lowering Drugs and Diet Network.

²Significant differences by t test between high- and low-SFA in participants with CC or TT genotype.